Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA

[1]  Y. Chardonnet,et al.  Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. , 1993, The Journal of investigative dermatology.

[2]  M. Barbareschi,et al.  p53 Protein expression in nevi and melanomas. , 1993, Archives of dermatology.

[3]  O. Ogunbiyi,et al.  Immunohistochemical analysis of p53 expression in anal squamous neoplasia. , 1993, Journal of clinical pathology.

[4]  C. Campbell,et al.  p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. , 1993, The Journal of investigative dermatology.

[5]  A. Ziegler,et al.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. Basset-Seguin,et al.  p53 gene mutations in human epithelial skin cancers. , 1993, Oncogene.

[7]  D. Lane,et al.  p53 protein expression in benign and malignant skin tumours , 1993, The British journal of dermatology.

[8]  I. Baas,et al.  Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. , 1993, The American journal of pathology.

[9]  Jean Kanitakis,et al.  Skin malignancies and human papillomaviruses in renal transplant recipients. , 1993, Transplantation proceedings.

[10]  Y. Chardonnet,et al.  Influence of fixation on human papillomavirus DNA detection in frozen and embedded paraffin lesions by in situ hybridization with biotinylated probes. , 1992, Pathology, research and practice.

[11]  T. Stephenson,et al.  Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma , 1992, The British journal of dermatology.

[12]  J. Schiller,et al.  Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes , 1992, Journal of virology.

[13]  S. Slater,et al.  Mutant p53 expression in solar keratosis: an immunohistochemical study , 1992, Journal of cutaneous pathology.

[14]  P. G. Prioleau,et al.  Overexpression of p53 protein in basal cell carcinomas of human skin. , 1992, The American journal of pathology.

[15]  S. Srivastava,et al.  The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. , 1992, Carcinogenesis.

[16]  J. McGregor,et al.  Aberrant expression of p53 tumour‐suppressor protein in non‐melanoma skin cancer , 1992, The British journal of dermatology.

[17]  E. Kawasaki,et al.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. , 1992, Journal of the National Cancer Institute.

[18]  Y. Chardonnet,et al.  Detection of multiple types of human papillomavirus in a giant condyloma from a grafted patient. Analysis by immunohistochemistry, in situ hybridisation, Southern blot and polymerase chain reaction. , 1992, Virus research.

[19]  D. Wynford‐Thomas.  P53 in tumour pathology: Can we trust immunocytochemistry? , 1992, The Journal of pathology.

[20]  Thierry Soussi,et al.  TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.

[21]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[22]  R. Geronemus,et al.  Detection of human papillomavirus DNA in squamous cell carcinoma of the nail bed and finger determined by polymerase chain reaction. , 1991, Archives of dermatology.

[23]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  W. Pierceall,et al.  Presence of human papilloma virus type 16 DNA sequences in human nonmelanoma skin cancers. , 1991, The Journal of investigative dermatology.

[25]  W. Thelmo,et al.  Verrucous carcinoma of the leg positive for human papillomavirus DNA 11 and 18: a case report. , 1991, Human pathology.

[26]  K. Vousden,et al.  Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation , 1991, Cell.

[27]  K. Münger,et al.  The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Medicine,et al.  Overexpression and mutation of p53 in epithelial ovarian cancer. , 1991, Cancer research.

[29]  T. Crook,et al.  p53 point mutation in HPV negative human cervical carcinoma cell lines. , 1991, Oncogene.

[30]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[31]  J. Bartek,et al.  Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro , 1990, International journal of cancer.

[32]  D. Lane,et al.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. , 1990, The EMBO journal.

[33]  A. Harris,et al.  Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.

[34]  E. Villiers.  Heterogeneity of the human papillomavirus group. , 1989 .

[35]  H. Hausen,et al.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers , 1989 .

[36]  E. Benton,et al.  HUMAN PAPILLOMA VIRUS INFECTION AND SKIN CANCER IN RENAL ALLOGRAFT RECIPIENTS , 1989, The Lancet.

[37]  E. Benton,et al.  HUMAN PAPILLOMAVIRUS TYPE 5 AND SKIN CANCER IN RENAL ALLOGRAFT RECIPIENTS , 1987, The Lancet.

[38]  F. Pass,et al.  Human papillomavirus heterogeneity in 36 renal transplant recipients. , 1987, Archives of dermatology.

[39]  Wolf,et al.  Immunologically distinct p53 molecules generated by alternative splicing , 1986, Molecular and cellular biology.

[40]  Magill Iw,et al.  Unexpected death following operation. , 1951 .

[41]  Y. Chardonnet,et al.  Study of stringency conditions for human papillomavirus DNA detection on cell lines, frozen and paraffin-embedded tissue sections by in situ hybridization with biotinylated probes , 2004, Histochemistry.

[42]  J. Bruner,et al.  p53 protein immunostaining in routinely processed paraffin-embedded sections. , 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[43]  D. Lane,et al.  High levels of p53 protein in UV-irradiated normal human skin. , 1993, Oncogene.

[44]  C. Péchoux,et al.  c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions. , 1992, Journal of dermatological science.

[45]  Y. Chardonnet,et al.  Evaluation of human papillomavirus type 5 on frozen sections of multiple lesions from transplant recipients with in situ hybridization and non-isotopic probes. , 1992, Dermatology.

[46]  W. Pierceall,et al.  Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas , 1991, Molecular carcinogenesis.

[47]  T. Crook,et al.  Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell lines , 1991, Molecular carcinogenesis.

[48]  D. Lane,et al.  p53: oncogene or anti-oncogene? , 1990, Genes & development.